Plasma leptin is not associated with prostate cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 5, 2003, Pages 474-475

  Stattin, Pär ^a   Kaaks, Rudolf ^b   Johansson, Robert ^a   Gislefoss, Randi ^c   Söderberg, Stefan ^a   Alfthan, Henrik ^d   Stenman, Ulf Håkan ^d   Jellum, Egil ^c   Olsson, Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LEPTIN; TESTOSTERONE;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

CASE-CONTROL STUDIES; HUMANS; LEPTIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 0037947313     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Rose. D. P., Gilhooly, E. M., and Nixon, D. W. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (Review). Int. J. Oncol., 21: 1285-1292, 2002.
2. Stattin, P., Söderberg, S., Hallmans, G., Bylund, A., Kaaks, R., Stenman U-H, Bergh, A., and Olsson, T. Leptin is associated with increased prostate cancer risk. A nested-case-referent study, J. Clin. Endocrinol. Metab., 86: 1341-1345, 2001.
3. Söderberg, S., Olsson, T., Eliasson, M., Johnson, O., Brismar, K. Carlström, K., and Ahren, B. A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity. Int. J. Obes. Relat. Metab. Disord., 25: 98-105, 2001.
4. Stattin, P., Adlercreutz, H., Tenkanen, L., Jellum, E., Lumme, S., Hallmans, G., Harvei, S., Teppo, L., Stumpf, K., Luostarinen, T., Lehtinen, M., Dillner, J., and Hakama, M. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int. J. Cancer. 99: 124-129, 2002.
5. Hsing, A. W., Chua, S., Jr., Gao, Y. T., Gentzschein, E., Chang, L., Deng, J., and Stanczyk, F. Z. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J. Natl. Cancer Inst. (Bethesda), 93: 783-789, 2001.